CRISPR/Cas mediated disruption of the glycolate oxidase gene is an efficacious treatment for primary hyperoxaluria type I
Journal article published in 2017 by
E. Salido,
A. Vales,
G. Gonzalez-Aseguinolaza,
N. Zabaleta,
F. Prosper,
G. Abizanda,
Juan Roberto Rodriguez-Madoz,
C. Olague,
S. Rodriguez 
,
M. Barberia
,
M. Barberia
